Acute emesis: moderately emetogenic chemotherapy
نویسندگان
چکیده
منابع مشابه
Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy.
BACKGROUND Although usually a problem of cisplatin-based chemotherapy, delayed emesis can cause severe distress in patients treated with cyclophosphamide. Dexamethasone has been shown to be effective in the control of cisplatin-induced delayed emesis, but its role against the delayed problem in patients treated with cyclophosphamide has not been demonstrated. Our study was conducted to evaluate...
متن کامل1504pincidence of Chemotherapy-induced Nausea and Vomiting with Moderately Emetogenic Chemotherapy: Advice Study.
Y. Escobar1, G. Cajaraville2, J. Virizuela3, R. Alvarez Alvarez1, A.J. Muñoz Martín4, O. Olariaga2, B. Muros5, M.J. Lecumberri Biurrun6, J. Feliu7, P. Martinez Del Prado8, J.J. Cruz Hernandez9, M.J. Martínez Bautista10, R. Lopez11, A. Blasco12, P. Gascon13, V. Calvo14, P. Luna Fra15, J. Montalar16, P. Del Barrio17, M.V. Tornamira17 Servicio de Oncología Médica, Hospital General Gregorio Marañon...
متن کاملOral granisetron for the prevention of acute late onset nausea and vomiting in patients treated with moderately emetogenic chemotherapy.
PURPOSE To demonstrate the efficacy of oral granisetron 1 mg twice daily for the prevention of late onset nausea and vomiting after moderately emetogenic chemotherapy that includes cyclophosphamide, carboplatin, or doxorubicin. METHODS Prior to chemotherapy, patients were stratified by gender and randomized to receive oral granisetron (1 mg tablet twice daily) or prochlorperazine (10 mg susta...
متن کاملUse of neurokinin-1 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy.
Chemotherapy-induced nausea and vomiting (CINV) is a serious adverse effect of chemotherapy that limits patients' physical, mental, and functional capabilities and may cause a delay or cessation of treatment. Antiemetic therapy can reduce the incidence of CINV. Research, using data from visits by patients receiving moderately (MEC) or highly emetogenic chemotherapy (HEC), identified that antiem...
متن کاملManagement of chemotherapy induced emesis
Important progress has been achieved in the last few years in the prevention of chemotherapy-induced nausea and vomiting thanks to the introduction in clinical practice first of the 5-HT3 antagonists and of the NK1 antagonists more recently. To prevent acute emesis induced by cisplatin/moderately emetogenic chemotherapy, a combination of aprepitant plus a 5-HT3 antagonist and dexamethasone/a 5-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Supportive Care in Cancer
سال: 2010
ISSN: 0941-4355,1433-7339
DOI: 10.1007/s00520-010-0951-5